“…By activating these GRs, glucocorticoids may affect reperfusion injury in a multitude of ways, including inhibition of leucocyte recruitment ( Perretti & Flower, 1993 ; Pitzalis et al ., 1997 ), reduction of vascular permeability ( Evans & Whittle, 2003 ; Romero et al ., 2003 ; Su et al ., 2004 ), inhibition of formation of cytokines or other mediators ( Almawi et al ., 1998 ; Turesin et al ., 2003 ) and modulation of enzyme systems involved in inflammation ( Koehler et al ., 1990 ; Kleinert et al ., 1996 ; Wallerath et al ., 2004 ). Potential mechanisms may involve modulation of neutrophil and endothelial function ( Korompilias et al ., 1996 ; Tjandra et al ., 1996 ; Takahira et al ., 2001 ), inhibition of formation of arachidonic acid products ( Turesin et al ., 2003 ) and attenuation of lipid peroxidation of biological membranes through membrane stabilization and scavenging of toxic‐free radicals ( Korompilias et al ., 1996 ; Marumo et al ., 1998 ). Here, treatment with dexamethasone totally suppressed the increase in vascular permeability, neutrophil influx and haemorrhage induced by reperfusion of the ischaemic SMA.…”